Ministry of Health finalises pact with Biological E for Covid-19 vaccine

Advanced arrangements made for 30 crore doses; Union Ministry of Health would be making an advance payment of Rs 1,500 crore to the Hyderabad company

Hyderabad: Union Ministry of Health has finalised arrangements with Hyderabad-based vaccine manufacturer Biological E to reserve 30 crore Covid-19 vaccine doses.

These vaccine doses will be manufactured and stockpiled by Biological E from August-December 2021. For this purpose, the Union Ministry of Health would be making an advance payment of Rs 1,500 crore to Biological E.

---

The Covid-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trials after showing promising results in Phase 1 and 2 clinical trials. The vaccine being developed by Biological-E is a receptor-binding domain (RBD) protein sub-unit vaccine and is likely to be available in the next few months.

The proposal of Biological-E was examined and recommended for approval after due diligence by the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC).

The arrangement with Biological-E is part of the wider endeavour of the Government of India to encourage indigenous vaccine manufacturers by providing them support in Research & Development (R&D) and also financial support.

Biological-E Covid vaccine candidate has been supported by Government of India from preclinical stage to Phase-3 studies. Department of Biotechnology has not only provided financial assistance in terms of grant-in-aid of over Rs 100 crore but has also  partnered with Biological-E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad.

---

Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

---